MENA Nutraceuticals Market, by Product type (Calcium Supplement Tablets and Gummies, Probiotics Supplement Tablets & Capsules, Collagen Peptide Powder Jar or Sachet, Iron in Tablet and Gummies & Syrup, Folic Acid Tablet, Pyridoxine Tablet, Rocket Seed Oil in Soft Gel, Prenatal Vitamin in Tablet and Gummies, Chaste Berry in Powder and Tablet and Capsule, Natural Eggshell Membrane in Capsule, Melatonin in Tablet, Vitamin C in Tablet, Inositol in Tablet, Whey Protein in Powder and Sachet, Biotin in Tablet, Hypericum perforatum Extract in Capsule, Vitamin D3 in Soft Gel Capsule and Gummies, Omega 3 in Soft Gel and Gummies, Omega 3 Plus Multivitamin in Soft Gel, Gummies Natural Eggshell Membrane in Capsule, CBD (CBD Tinctures, Capsules & Soft gels, CBD Gummies, Others), and Others), by Application (Cancer, Diabetes, Heart Disorders, Hypertension, Obesity, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Convenience Store, Hypermarket/ Supermarket and Online Pharmacies), and by Region (Middle East and North Africa)  was valued at US$ 13,051.5 Million in 2021 and is projected to exhibit a CAGR of 7.1% during the forecast period (2021-2028).

Cannabidiol (CBD) is a chemical found in the cannabis sativa plant, also known as cannabis or hemp. CBD is used for the treatment of anxiety, pain, a muscle condition called dystonia, Parkinson's disease, Crohn's disease, and many other conditions, but there is no good scientific evidence for these uses. The governments of some countries in MENA region such as Lebanon, Australia, Israel, and others have accepted the potential uses of cannabidiol in the medical industry and support legalization for medical purposes. This is expected to create lucrative opportunities for CBD market participants. According to the Centers for Disease Control and Prevention (CDC) Cannabis Strategy 2020-2025, CDC is involved in reviewing the evidence of the effectiveness of cannabis as a medical treatment such as for pain management, treatment of opioid use disorder, and is continuing to inform the same through medical education. Moreover, in March 2021, the Moroccan government passed a law to legalize cannabis for medical, cosmetic, and industrial purposes.

MENA Nutraceuticals Market – Impact of Coronavirus (COVID-19) Pandemic

COVID-19 pandemic has affected various industries globally. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally, as of December 1, 2021, are approximately 262,178,403 confirmed cases with 5,215,745 deaths.

According to an article published by the Nutrition and Dietary Supplements in February 2021, nutraceuticals provides health benefits such as strengthening immunity to fight COVID-19 infection and therefore is positively impacting the MENA nutraceuticals market. Nutraceuticals such as polyphenols, leguminous seeds containing plant protease inhibitors, whey protein or jackfruit seed protein, when taken as a dietary supplement, have been demonstrated to be useful in boosting immunity.

Moreover, according to an article published by the Molecules Journal in December 2020, COVID-19 patients are at significant risk of co-morbidities related with liver injury & dysfunction and the use of antiviral therapy has prompted concerns about hepatotoxity. This has perked scientists' interest in developing new nutraceuticals, which offer a wide range of health benefits such as antiviral, immunomodulatory, and hepatoprotective properties.

Browse 55 Market Data Tables and 56 Figures spread through 327 Pages and in-depth TOC on “ MENA Nutraceuticals Market”-  Forecast to 2028,  MENA Nutraceuticals market, by Product type (Calcium Supplement Tablets and Gummies, Probiotics Supplement Tablets & Capsules, Collagen Peptide Powder Jar or Sachet, Iron in Tablet and Gummies & Syrup, Folic Acid Tablet, Pyridoxine Tablet, Rocket Seed Oil in Soft Gel, Prenatal Vitamin in Tablet and Gummies, Chaste Berry in Powder and Tablet and Capsule, Natural Eggshell Membrane in Capsule, Melatonin in Tablet, Vitamin C in Tablet, Inositol in Tablet, Whey Protein in Powder and Sachet, Biotin in Tablet, Hypericum perforatum Extract in Capsule, Vitamin D3 in Soft Gel Capsule and Gummies, Omega 3 in Soft Gel and Gummies, Omega 3 Plus Multivitamin in Soft Gel, Gummies Natural Eggshell Membrane in Capsule, CBD (CBD Tinctures, Capsules & Soft Gels, CBD Gummies, Others), and Others), by Application (Cancer, Diabetes, Heart Disorders, Hypertension, Obesity and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Convenience Store, Hypermarket/ Supermarket and Online Pharmacies), and by Region (Middle East and North Africa)  - Forecast to 2028

To know the latest trends and insights prevalent in the MENA Nutraceuticals Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/mena-nutraceuticals-market-3795

Key players are focusing on R&D activities to develop new nutraceuticals, which is expected to drive the growth of MENA nutraceuticals market over the forecast period. For instance, according to a review article published by The North African Journal of Food and Nutrition Research in July 2021, a research study jointly conducted by collaboration of Université de Bouira, Universidade de Lisboa, Portugal, and Université de Jijel, Algérie for determining the effect of ultrasonic and microwave treatment on Ziziphus lotus (L.) Lam plant. Results showed that ultrasonic and microwave treatment of Ziziphus lotus (L.) Lam plants improves the yield and quality of antioxidants and extracts of these antioxidants can continue to be used as potential ingredients in dietary supplement development.

Key Takeaways of the MENA Nutraceuticals market:

  • MENA nutraceuticals market is expected to exhibit a CAGR of 7.1% during the forecast period, owing to government activities in the Middle East and North Africa to ensure access to safe, nutritious, and sufficient food. This is expected to fuel growth of the MENA nutraceuticals market. For instance, in November 2018, the UAE government announced the National Food Security Strategy 2051 to assure zero hunger by supporting organic and local farming and investing in the production of high-quality food with improved nutrition.
  • Among product type, Folic acid tablet segment is expected to lead the MENA nutraceuticals market, owing to the awareness initiatives by government for ensuring adequate folic acid consumption. For instance, in November 2019, Dubai Health Authority’s (DHA) Latifa Women and Children Hospital announced implementation of new guidelines for folic acid consumption in all married women of childbearing age to reduce the incidence of birth defects related to spinal cord and brain.
  • Among application, heart disorders segment is estimated to account for 22.8% market share in 2021. Heart disorders may cause severe damage to one’s health and nutraceuticals have been found to show positive results in maintaining heart health. This is expected to fuel growth of heart disorders segment over the forecast period. For instance, according to the data provided by the World Heart Federation published in 2019, it is estimated that cardiovascular disease, a type of heart disorder is the major cause of deaths in the Middle East & North Africa region causing around one third of all deaths in 2019.
  • Major players operating in the MENA nutraceuticals market include Nestlé S.A., Danone Nutricia, Unilever, Bionova Lifesciences, BASF SE, Abbott Laboratories, Arkopharma Laboratories, GlaxoSmithKline, Archer Daniels Midland Company, DuPont, Kellogg’s, Arla Foods, Koninklijke DSM N.V., Quantum Naturals Ltd., Adcock Ingram, Ascendis Health Limited, iNova Pharmaceuticals, Vital Health Foods, Jamjoom Pharma, Creso Pharma, and ConnOils LLC.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo